Collaborations & PartnershipsNF1Press ReleaseScience & Research SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for NF1 Patients
Collaborations & PartnershipsNF1NF2-SWNSWN NF Collective Launches New Website to Connect NF Patients with Doctors
Collaborations & PartnershipsNF2-SWNPress ReleaseScience & Research Children’s Tumor Foundation Provides Funding to NF2 Therapeutics, Inc. to Develop a First-in-Class Gene Therapy for NF2-related schwannomatosis
Collaborations & PartnershipsNF1Press ReleasePublicationsScience & Research Nerve Fibers in Skin Are Involved in Initiating Neurofibromas in Patients with Disfiguring Neurofibromatosis 1
Collaborations & PartnershipsNF1PublicationsScience & Research Research Published from Synodos Group Developing Pig Models
Collaborations & PartnershipsNF1Video Synodos for NF1 is Changing the World for Low Grade Glioma Patients
Collaborations & PartnershipsCTF in the NewsNF1PublicationsScience & Research Funders Collaborate to Efficiently Develop Treatments for Rare Childhood Tumors
